DRUG · Mapped RxNorm record
Norepinephrine
Normalized identity: norepinephrineView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Exploratory Study of Norepinephrine to Prevent Radiodermatitis in Breast Cancer Patients
NCT01263366
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedExploratory Study of Norepinephrine to Prevent Radiodermatitis in Breast Cancer Patients
Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Radiodermatitisverified · MONDO: radiodermatitis
Interventions
NorepinephrineDRUG · verified · RxNorm: norepinephrine
Sponsors & collaborators
ProCertus BioPharm, Inclead sponsor
University of Wisconsin, Madisoncollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01263366 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.